Penserra Capital Management LLC Has $1.15 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

Penserra Capital Management LLC raised its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 147.6% during the first quarter, according to its most recent filing with the SEC. The firm owned 3,320 shares of the company's stock after purchasing an additional 1,979 shares during the period. Penserra Capital Management LLC's holdings in HCA Healthcare were worth $1,146,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the stock. Maj Invest Holding A S acquired a new position in shares of HCA Healthcare during the 1st quarter valued at $109,823,000. Concurrent Investment Advisors LLC lifted its position in shares of HCA Healthcare by 5.2% during the 1st quarter. Concurrent Investment Advisors LLC now owns 2,142 shares of the company's stock valued at $740,000 after acquiring an additional 106 shares during the period. Seascape Capital Management lifted its position in shares of HCA Healthcare by 0.9% during the 1st quarter. Seascape Capital Management now owns 13,575 shares of the company's stock valued at $4,691,000 after acquiring an additional 117 shares during the period. Wayfinding Financial LLC bought a new stake in HCA Healthcare during the 1st quarter valued at $113,000. Finally, Olde Wealth Management LLC bought a new stake in HCA Healthcare during the 1st quarter valued at $76,000. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Price Performance

HCA stock opened at $377.71 on Wednesday. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.19 and a quick ratio of 1.06. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The stock has a market cap of $90.87 billion, a PE ratio of 16.79, a P/E/G ratio of 1.31 and a beta of 1.47. The firm has a 50 day simple moving average of $373.21 and a two-hundred day simple moving average of $340.45.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The company had revenue of $18.32 billion during the quarter, compared to analysts' expectations of $18.26 billion. During the same quarter in the prior year, the company earned $5.36 EPS. The firm's revenue was up 5.7% on a year-over-year basis. On average, analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, June 30th. Shareholders of record on Monday, June 16th were given a dividend of $0.72 per share. The ex-dividend date was Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.76%. HCA Healthcare's payout ratio is currently 12.81%.

Insiders Place Their Bets

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the sale, the chief operating officer owned 12,646 shares of the company's stock, valued at $4,670,420.72. This represents a 55.38% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 1.30% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of brokerages have commented on HCA. Morgan Stanley set a $410.00 price target on shares of HCA Healthcare and gave the company an "equal weight" rating in a research note on Monday, June 9th. Wells Fargo & Company upgraded shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and upped their target price for the stock from $320.00 to $385.00 in a research note on Thursday, May 29th. Robert W. Baird restated a "neutral" rating and set a $336.00 price objective (down previously from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday. Finally, Barclays set a $416.00 price target on shares of HCA Healthcare and gave the company an "overweight" rating in a research report on Monday, June 2nd. Seven analysts have rated the stock with a hold rating, eleven have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, HCA Healthcare currently has an average rating of "Moderate Buy" and an average price target of $395.71.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.